Sage Journals: Discover world-class research

Abstract

Although less than 1% of patients with the antiphospholipid syndrome (APS) develop the catastrophic variant, its potentially lethal outcome emphasises its importance in clinical medicine today. However, the rarity of this variant makes it extraordinarily difficult to study in any systematic way. To put together all the published case reports as well as the new diagnosed cases from all over the world, an international registry of patients with catastrophic APS (CAPS Registry) was created in 2000 by the European Forum on Antiphospholipid Antibodies. Currently, it documents the entire clinical, laboratory and therapeutic data of more than 300 patients whose data has been fully registered. This registry can be freely consulted at the Internet (http://www.med.ub.es/MIMMUN/FORUM/CAPS.HTM), and it is expected that the periodical analysis of these data will allow us to increase our knowledge of this condition.

Keywords

anticardiolipin antibodies antiphospholipid antibodies antiphospholipid syndrome catastrophic antiphospholipid syndrome lupus anticoagulant

Get full access to this article

View all access options for this article.

References

1 Asherson RA . The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508–512.

2 Piette JC Cervera R Levy R Nasonov EL Triplett DA Shoenfeld Y . The catastrophic antiphospholipid syndrome Asherson’s syndrome. Ann Med Interne 2003; 154: 95–96.

3 Asherson RA Cervera R Piette JC . Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998; 77: 195–207.

4 Asherson RA Cervera R Piette JC . Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001; 80: 355–376.

5 Cervera R Piette JC Font J . Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002; 46: 1019–1027.

6 Asherson RA Cervera R de Groot PR . Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530–534.

7 Cervera R Font J Gómez-Puerta JA . Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005; 64: 1205–1209.

8 Asherson RA Shoenfeld Y . The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome – molecular mimicry? J Rheumatol 2000; 27: 12–14.

9 Bucciarelli S Espinosa G Asherson RA . The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 2006; 65: 81–86.

10.

10 Asherson RA Espinosa G Cervera R . Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis 2005; 64: 943–946.

11.

11 Bucciarelli S Espinosa G Cervera R . Mortality in catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006; 54: 2568–2576.

12.

12 Espinosa G Bucciarelli S Cervera R . Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 2004; 63: 730–736.

13.

13 Bucciarelli S Cervera R Espinosa G . Mortality of the catastrophic antiphospholipid síndrome: causes of death and prognostic factors. Autoimmun Rev 2006; 6: 72–75.

14.

14 Bayraktar UD Erkan D Bucciarelli S Espinosa G Asherson RA ; for the Catastrophic Antiphospholipid Syndrome Project Group. The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol 2007; 34: 346–352.

15.

15 Erkan D Asherson RA Espinosa G . Long term outcome of catastrophic antiphospholipid síndrome survivors. Ann Rheum Dis 2003; 62: 530–533.

16.

16 Asherson R Espinosa G Menahen S . Relapsing catastrophic antiphsopholipid syndrome: report of three cases. Semin Arthritis Rheum 2008; 37: 366–372.

17.

The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome

Abstract

Keywords

Get full access to this article

References